| Serial Number | 97901547 |
| Word Mark | ENGAGER T |
| Filing Date | Friday, April 21, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, June 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Therapeutic pharmaceutical for the treatment of cancer and tumors |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | IMMUNEBRO THERAPEUTICS INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60607 |
| Event Date | Event Description |
| Thursday, May 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 25, 2023 | NEW APPLICATION ENTERED |
| Thursday, January 18, 2024 | ASSIGNED TO EXAMINER |
| Friday, January 26, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, January 26, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, January 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 30, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 12, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, June 12, 2024 | FINAL REFUSAL E-MAILED |
| Wednesday, June 12, 2024 | FINAL REFUSAL WRITTEN |